Lungpacer Medical announced that it received FDA investigational device exemption (IDE) approval to begin a trial for its ...

The investigational AeroNova® System delivers continual diaphragm neurostimulation in conjunction with mechanical ventilation ...

Repeated sessions of electrical stimulation to brain networks associated with memory improved verbal learning in some ...

UCSD has initiated a clinical trial to assess Nexalin Technology's Halo Clarity device for treating mTBI and PTSD.

Neurostimulation devices use electrical impulses to modulate nervous system activity, helping treat chronic pain, neurological disorders, and mental health conditions. ” - Exactitude Consultancy ...

Spark Biomedical, a leader in wearable neurostimulation technology, announces the receipt of its Medical Device License from Health Canada for Sparrow AscentTM, an FDA-cleared non-invasive, drug-free, ...

This milestone follows the successful IRB approval, pilot testing and evaluation of Nexalin’s Halo technology at UCSD. The study will evaluate Nexalin’s proprietary Deep Intracranial Frequency ...

Sleep Apnea Implants MarketThe global sleep apnea implants market is projected to grow at a CAGR of 3.8% from 2024 to 2035, ...

Introduction to the Nerve Repair MarketThe nerve repair market is a rapidly growing sector within the healthcare and medical ...